Daiichi Sankyo
Sharon Mark-Asante is a seasoned professional in clinical trial management with extensive experience in the pharmaceutical industry. Currently serving as Sr. Clinical Trial Manager at Daiichi Sankyo, Inc. since September 2016, Sharon previously held the position of Sr. Clinical Study Manager at Novartis Pharmaceuticals for one year and spent nearly nine years at Novartis Pharmaceuticals Corporation in various roles, including Clinical Trial Associate and Clinical Trial Assistant. Early career experience includes finance and budget management at Organon Pharmaceuticals. Sharon holds a Master of Science in Clinical Research Administration from Walden University, a Bachelor of Arts in Liberal Arts from Thomas Edison State University, and an Associate of Arts in Business from Borough of Manhattan Community College.
This person is not in the org chart
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.